Intellia Therapeutics, Inc. (NTLA)

9.23 +0.24 (+2.67%) USD  |  NASDAQ  |  Jan 02, 09:42
More

Intellia Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. --
Vertex Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. --